BOTHWELL IAN T 4

4 · Zeo ScientifiX, Inc. · Filed Jun 12, 2026

AI-generated summary of this filing

Updated Jun 12, 2026

Zeo ScientifiX (ZEOX) 10% Owner Ian Bothwell Receives Option Awards

What Happened

Ian T. Bothwell, a 10% owner of Zeo ScientifiX, was awarded two stock option grants on 2026-06-10: 625,000 options (Grant A) and 625,000 options (Grant B), for a total of 1,250,000 options. The filing records $0 acquisition value because these are option awards (derivative securities), not purchases of common stock.

Key Details

Transaction date: 2026-06-10; Filing date: 2026-06-12 (appears timely).
Reported price: $0.00 (reflects grant of derivative securities, not a cash purchase).
Shares owned after transaction: not specified in the provided filing details.
Footnotes:
- F1: One option grant vested in full as of the grant date and is exercisable on a cashless basis for 10 years from the award date.
- F2: The other grant vests upon achievement of specified performance milestones, is exercisable cashless once vested for up to 10 years, and is antidilutive for any future transaction issuing ≥10% of the company's fully diluted common stock.
Transaction type: Award/Grant of options (derivative transaction), not a sale or open-market purchase.

Context

These are option awards (derivatives). “Cashless” exercise generally allows the holder to convert options into net shares without paying cash up front (the company withholds shares to cover exercise price/taxes), but does not guarantee an immediate sale or cash proceeds.
As a 10% owner, Bothwell is a principal holder; such awards affect insider ownership but are not the same signal as an outright purchase or sale of common stock.

Form 4

Period: 2026-06-10

DirectorCEO & CFO10% Owner

Transactions

Award
Stock Options
[F1]
2026-06-10+625,000→ 625,000 total
Exercise: $1.67From: 2026-06-10Exp: 2036-06-10→ Common Stock (625,000 underlying)
Award
Stock Options
[F2]
2026-06-10+625,000→ 625,000 total
Exercise: $1.67From: 2026-06-10Exp: 2036-06-10→ Common Stock (625,000 underlying)

Footnotes (2)

[F1]Represents the grant of stock options to purchase shares of the Issuer's common stock under its 2021 Equity Incentive Plan (the "2021 Plan"). The options vested in full as of the grant date, are exercisable on a "cashless basis" for a period of ten (10) years from the award date, and are subject to the other terms and conditions of the 2021 Plan.
[F2]Represents the grant of stock options to purchase shares of the Issuer's common stock under the 2021 Plan. The options vest upon the achievement of certain performance milestones, are exercisable on a "cashless basis" during the period commencing on the date they vest and ending ten (10) years from the award date, and are subject to the other terms and conditions of the 2021 Plan. The options are antidilutive for any future transaction that provides for the issuance of 10% or more of the Company's common stock outstanding on a fully diluted basis.

Signature

/s/ Ian T. Bothwell|2026-06-12

1 file